Filed: 2/17/2026ACC: 0001583977-26-000001
📋 What this filing means
CORMORANT ASSET MANAGEMENT, LP filed this quarterly 13F‑HR report disclosing 35 equity positions with a total reported market value of $2.16B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
35
Positions
$2.16B
Total AUM (reported)
71.56M
Total Shares
Allocation by class
COM NEW$756.60M35.0%
COM$614.02M28.4%
SPONSORED ADS$215.19M10.0%
UNIT SER 1$153.58M7.1%
RUSSELL 2000 ETF$123.08M5.7%
STATE STREET SPD$121.93M5.6%
CLASS A ORD$57.40M2.7%
Portfolio Concentration
Top 3$685.90M31.7%
4–10$815.90M37.7%
11–25$565.12M26.1%
Rest$95.66M4.4%
Top 3 weight
31.7%
Top 10 weight
69.4%
Voting Authority Distribution
Total shares with voting rights: 71.56M
Sole
Full voting authority
71.56M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole0
Shared0
Other35
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings35
Rows:
PRAXIS PRECISION MEDICINES I
DFNDShares950K
TypeSH
Market value$280.00M
12.95%
Sole
950K
Shared
0.00
None
0.00
BRIDGEBIO ONCOLOGY THERAPEUT
DFNDShares17.88M
TypeSH
Market value$223.84M
10.35%
Sole
17.88M
Shared
0.00
None
0.00
ABIVAX SA
DFNDShares1.35M
TypeSH
Market value$182.05M
8.42%
Sole
1.35M
Shared
0.00
None
0.00
INVESCO QQQ TR
DFNDShares250K
TypeSH
Market value$153.58M
7.10%
Sole
250K
Shared
0.00
None
0.00
EYEPOINT INC
DFNDShares8.27M
TypeSH
Market value$151.00M
6.98%
Sole
8.27M
Shared
0.00
None
0.00
ISHARES TR
DFNDShares500K
TypeSH
Market value$123.08M
5.69%
Sole
500K
Shared
0.00
None
0.00
SPDR SERIES TRUST
DFNDShares1M
TypeSH
Market value$121.93M
5.64%
Sole
1M
Shared
0.00
None
0.00
RAPPORT THERAPEUTICS INC
DFNDShares3.03M
TypeSH
Market value$91.85M
4.25%
Sole
3.03M
Shared
0.00
None
0.00
BRIDGEBIO PHARMA INC
DFNDShares1.20M
TypeSH
Market value$91.79M
4.24%
Sole
1.20M
Shared
0.00
None
0.00
BRIGHT MINDS BIOSCIENCES INC
DFNDShares1.06M
TypeSH
Market value$82.67M
3.82%
Sole
1.06M
Shared
0.00
None
0.00
EDGEWISE THERAPEUTICS INC
DFNDShares3.29M
TypeSH
Market value$81.52M
3.77%
Sole
3.29M
Shared
0.00
None
0.00
OLEMA PHARMACEUTICALS INC
DFNDShares2.75M
TypeSH
Market value$68.75M
3.18%
Sole
2.75M
Shared
0.00
None
0.00
MOONLAKE IMMUNOTHERAPEUTICS
DFNDShares4.36M
TypeSH
Market value$57.40M
2.65%
Sole
4.36M
Shared
0.00
None
0.00
INSMED INC
DFNDShares275K
TypeSH
Market value$47.86M
2.21%
Sole
275K
Shared
0.00
None
0.00
ENGENE HOLDINGS INC
DFNDShares4M
TypeSH
Market value$36.12M
1.67%
Sole
4M
Shared
0.00
None
0.00
ALUMIS INC
DFNDShares3.64M
TypeSH
Market value$35.48M
1.64%
Sole
3.64M
Shared
0.00
None
0.00
MBX BIOSCIENCES INC
DFNDShares1.12M
TypeSH
Market value$35.32M
1.63%
Sole
1.12M
Shared
0.00
None
0.00
NEWAMSTERDAM PHARMA COMPANY
DFNDShares1M
TypeSH
Market value$35.08M
1.62%
Sole
1M
Shared
0.00
None
0.00
CENTESSA PHARMACEUTICALS PLC
DFNDShares1.32M
TypeSH
Market value$33.14M
1.53%
Sole
1.32M
Shared
0.00
None
0.00
PHARVARIS N V
DFNDShares1.08M
TypeSH
Market value$30.05M
1.39%
Sole
1.08M
Shared
0.00
None
0.00
BIOAGE LABS INC
DFNDShares2.04M
TypeSH
Market value$27.00M
1.25%
Sole
2.04M
Shared
0.00
None
0.00
ASCENDIS PHARMA A/S
DFNDShares100K
TypeSH
Market value$21.32M
0.99%
Sole
100K
Shared
0.00
None
0.00
TARSUS PHARMACEUTICALS INC
DFNDShares250K
TypeSH
Market value$20.47M
0.95%
Sole
250K
Shared
0.00
None
0.00
CORBUS PHARMACEUTICALS HLDGS
DFNDShares2.34M
TypeSH
Market value$19.09M
0.88%
Sole
2.34M
Shared
0.00
None
0.00
GH RESEARCH PLC
DFNDShares1.30M
TypeSH
Market value$16.51M
0.76%
Sole
1.30M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
PRAXIS PRECISION MEDICINES IDFND | COM NEW | 950K | SH | $280.00M 12.95% | 950K | 0.00 | 0.00 |
BRIDGEBIO ONCOLOGY THERAPEUTDFND | COM NEW | 17.88M | SH | $223.84M 10.35% | 17.88M | 0.00 | 0.00 |
ABIVAX SADFND | SPONSORED ADS | 1.35M | SH | $182.05M 8.42% | 1.35M | 0.00 | 0.00 |
INVESCO QQQ TRDFND | UNIT SER 1 | 250K | SH | $153.58M 7.10% | 250K | 0.00 | 0.00 |
EYEPOINT INCDFND | COM NEW | 8.27M | SH | $151.00M 6.98% | 8.27M | 0.00 | 0.00 |
ISHARES TRDFND | RUSSELL 2000 ETF | 500K | SH | $123.08M 5.69% | 500K | 0.00 | 0.00 |
SPDR SERIES TRUSTDFND | STATE STREET SPD | 1M | SH | $121.93M 5.64% | 1M | 0.00 | 0.00 |
RAPPORT THERAPEUTICS INCDFND | COM | 3.03M | SH | $91.85M 4.25% | 3.03M | 0.00 | 0.00 |
BRIDGEBIO PHARMA INCDFND | COM | 1.20M | SH | $91.79M 4.24% | 1.20M | 0.00 | 0.00 |
BRIGHT MINDS BIOSCIENCES INCDFND | COM NEW | 1.06M | SH | $82.67M 3.82% | 1.06M | 0.00 | 0.00 |
EDGEWISE THERAPEUTICS INCDFND | COM | 3.29M | SH | $81.52M 3.77% | 3.29M | 0.00 | 0.00 |
OLEMA PHARMACEUTICALS INCDFND | COM | 2.75M | SH | $68.75M 3.18% | 2.75M | 0.00 | 0.00 |
MOONLAKE IMMUNOTHERAPEUTICSDFND | CLASS A ORD | 4.36M | SH | $57.40M 2.65% | 4.36M | 0.00 | 0.00 |
INSMED INCDFND | COM PAR $.01 | 275K | SH | $47.86M 2.21% | 275K | 0.00 | 0.00 |
ENGENE HOLDINGS INCDFND | COM | 4M | SH | $36.12M 1.67% | 4M | 0.00 | 0.00 |
ALUMIS INCDFND | COM | 3.64M | SH | $35.48M 1.64% | 3.64M | 0.00 | 0.00 |
MBX BIOSCIENCES INCDFND | COM | 1.12M | SH | $35.32M 1.63% | 1.12M | 0.00 | 0.00 |
NEWAMSTERDAM PHARMA COMPANYDFND | ORDINARY SHARES | 1M | SH | $35.08M 1.62% | 1M | 0.00 | 0.00 |
CENTESSA PHARMACEUTICALS PLCDFND | SPONSORED ADS | 1.32M | SH | $33.14M 1.53% | 1.32M | 0.00 | 0.00 |
PHARVARIS N VDFND | COM | 1.08M | SH | $30.05M 1.39% | 1.08M | 0.00 | 0.00 |
BIOAGE LABS INCDFND | COM | 2.04M | SH | $27.00M 1.25% | 2.04M | 0.00 | 0.00 |
ASCENDIS PHARMA A/SDFND | SPONSORED ADR | 100K | SH | $21.32M 0.99% | 100K | 0.00 | 0.00 |
TARSUS PHARMACEUTICALS INCDFND | COM | 250K | SH | $20.47M 0.95% | 250K | 0.00 | 0.00 |
CORBUS PHARMACEUTICALS HLDGSDFND | COM NEW | 2.34M | SH | $19.09M 0.88% | 2.34M | 0.00 | 0.00 |
GH RESEARCH PLCDFND | ORDINARY SHARES | 1.30M | SH | $16.51M 0.76% | 1.30M | 0.00 | 0.00 |
Page 1 of 2